
Jose M. Mesa
Examiner (ID: 7325, Phone: (571)270-1706 , Office: P/2484 )
| Most Active Art Unit | 2484 |
| Art Unit(s) | 2484 |
| Total Applications | 760 |
| Issued Applications | 560 |
| Pending Applications | 54 |
| Abandoned Applications | 178 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5304261
[patent_doc_number] => 20090298913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'SMALL INTERFERING OLIGONUCLEOTIDES COMPRISING ARABINOSE MODIFIED NUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/091318
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6808
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091318 | SMALL INTERFERING OLIGONUCLEOTIDES COMPRISING ARABINOSE MODIFIED NUCLEOTIDES | Oct 25, 2006 | Abandoned |
Array
(
[id] => 4746173
[patent_doc_number] => 20080090775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Antagonist of TEB4 and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/551939
[patent_app_country] => US
[patent_app_date] => 2006-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6672
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090775.pdf
[firstpage_image] =>[orig_patent_app_number] => 11551939
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/551939 | Antagonist of TEB4 and Methods of Use | Oct 22, 2006 | Abandoned |
Array
(
[id] => 5205621
[patent_doc_number] => 20070027103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Methods and compositions for silencing genes without inducing toxicity'
[patent_app_type] => utility
[patent_app_number] => 11/542291
[patent_app_country] => US
[patent_app_date] => 2006-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 32907
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542291 | Methods and compositions for silencing genes without inducing toxicity | Oct 2, 2006 | Abandoned |
Array
(
[id] => 4971926
[patent_doc_number] => 20070111929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Methods for the treatment of anxiety and for identification of anxiolytic agents'
[patent_app_type] => utility
[patent_app_number] => 11/508441
[patent_app_country] => US
[patent_app_date] => 2006-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8734
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111929.pdf
[firstpage_image] =>[orig_patent_app_number] => 11508441
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/508441 | Methods for the treatment of anxiety and for identification of anxiolytic agents | Aug 22, 2006 | Abandoned |
Array
(
[id] => 92562
[patent_doc_number] => 07732591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Compositions, devices and methods for treatment of huntington\'s disease through intracranial delivery of sirna'
[patent_app_type] => utility
[patent_app_number] => 11/501147
[patent_app_country] => US
[patent_app_date] => 2006-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13570
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732591.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501147 | Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna | Aug 7, 2006 | Issued |
Array
(
[id] => 5643247
[patent_doc_number] => 20060281702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Combinatorial selection of phosphorothioate aptamers for RNases'
[patent_app_type] => utility
[patent_app_number] => 11/435907
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11892
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281702.pdf
[firstpage_image] =>[orig_patent_app_number] => 11435907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/435907 | Combinatorial selection of phosphorothioate aptamers for RNases | May 16, 2006 | Abandoned |
Array
(
[id] => 5887539
[patent_doc_number] => 20060275263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/434813
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11923
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275263.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434813
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434813 | Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy | May 16, 2006 | Abandoned |
Array
(
[id] => 5688954
[patent_doc_number] => 20060287269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Short interfering nucleic acid hybrids and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 11/434836
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6166
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287269.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434836 | Short interfering nucleic acid hybrids and methods thereof | May 14, 2006 | Abandoned |
Array
(
[id] => 5154881
[patent_doc_number] => 20070037764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells'
[patent_app_type] => utility
[patent_app_number] => 11/433257
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12872
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11433257
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/433257 | Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells | May 10, 2006 | Abandoned |
Array
(
[id] => 5733491
[patent_doc_number] => 20060258608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'RNAi modulation of RSV and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/411291
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16800
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258608.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411291 | RNAi modulation of RSV and therapeutic uses thereof | Apr 25, 2006 | Issued |
Array
(
[id] => 5136473
[patent_doc_number] => 20070078102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'NF-kB oligonucleotide decoy molecules'
[patent_app_type] => utility
[patent_app_number] => 11/368060
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 28601
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20070078102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11368060
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/368060 | NF-kB oligonucleotide decoy molecules | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5596206
[patent_doc_number] => 20060160123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Method of minimizing off-target effects of siRNA molecules'
[patent_app_type] => utility
[patent_app_number] => 11/361793
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12382
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11361793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361793 | Method of minimizing off-target effects of siRNA molecules | Feb 23, 2006 | Abandoned |
Array
(
[id] => 5760073
[patent_doc_number] => 20060211018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Nucleozymes and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/350304
[patent_app_country] => US
[patent_app_date] => 2006-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13394
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11350304
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/350304 | Nucleozymes and methods of use | Feb 7, 2006 | Abandoned |
Array
(
[id] => 4740564
[patent_doc_number] => 20080234217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Inhibitor Nucleic Acids'
[patent_app_type] => utility
[patent_app_number] => 11/883219
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23102
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234217.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883219 | Inhibitor Nucleic Acids | Jan 25, 2006 | Abandoned |
Array
(
[id] => 5188416
[patent_doc_number] => 20070166724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'MICRORNAS AND RELATED NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 11/275628
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15330
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11275628
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/275628 | MICRORNAS AND RELATED NUCLEIC ACIDS | Jan 18, 2006 | Abandoned |
Array
(
[id] => 334397
[patent_doc_number] => 07507809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'RNAi modulation of RSV and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/326956
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 16910
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507809.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326956 | RNAi modulation of RSV and therapeutic uses thereof | Jan 5, 2006 | Issued |
Array
(
[id] => 5688949
[patent_doc_number] => 20060287264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'RNAi modulation of the BCR-ABL fusion gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/286624
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18084
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287264.pdf
[firstpage_image] =>[orig_patent_app_number] => 11286624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/286624 | RNAi modulation of the BCR-ABL fusion gene and uses thereof | Nov 22, 2005 | Abandoned |
Array
(
[id] => 5777339
[patent_doc_number] => 20060105979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Synergistic inhibition of VEGF and modulation of the immune response'
[patent_app_type] => utility
[patent_app_number] => 11/269862
[patent_app_country] => US
[patent_app_date] => 2005-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3919
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105979.pdf
[firstpage_image] =>[orig_patent_app_number] => 11269862
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/269862 | Synergistic inhibition of VEGF and modulation of the immune response | Nov 7, 2005 | Abandoned |
Array
(
[id] => 5924098
[patent_doc_number] => 20060241075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 11/259603
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 88618
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241075.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259603 | RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA) | Oct 25, 2005 | Abandoned |
Array
(
[id] => 5672973
[patent_doc_number] => 20060178328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA'
[patent_app_type] => utility
[patent_app_number] => 11/253393
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25925
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253393
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253393 | Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA | Oct 18, 2005 | Issued |